Articles
- Vagus nerve stimulation therapy summaryFive years after FDA approvalSteven C. Schachter
- Vagus nerve stimulation therapy in patients younger than 18 yearsJames W. Wheless, Vijay Maggio
- Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsyJ. Ben Renfroe, James W. Wheless
- Vagus nerve stimulation therapy, epilepsy, and device parametersScientific basis and recommendations for useChristi Heck, Sandra L. Helmers, Christopher M. DeGiorgio
- Analysis of direct hospital costs before and 18 months after treatment with vagus nerve stimulation therapy in 43 patientsElinor Ben-Menachem, Karina Hellström, Daniel Verstappen
- Vagus nerve stimulation therapyA research updateM.S. George, Z. Nahas, D.E. Bohning, F.A. Kozel, B. Anderson, J.-H. Chae, M. Lomarev, S. Denslow, X. Li, C. Mu
Introduction
- The evolving place of vagus nerve stimulation therapySteven C. Schachter, James W. Wheless
Advertisement
Popular on
Neurology

Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Advertisement